{
  "id": 1613128,
  "title": "Why is Cochlear stock surging today?",
  "url": "https://urgent.news/2026/08/18/why-is-cochlear-stock-surging-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-18T02:13:03.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-cochlear-stock-surging-today-93CH-4864216"
  },
  "original_language": "en",
  "account": "Cochlear's shares jumped 7% to A$140.48 after the hearing implant company reported earnings that beat expectations. The company's underlying net profit for the year ended June 30 fell 22% to A$322.4 million, slightly below forecasts of A$303.9 million. However, cost reductions and improving margins helped offset weaker demand and currency issues. For 2027, Cochlear expects low single-digit revenue growth and net profit between A$330 million and A$350 million. The stock rally is driven by optimism stemming from the company's revised expectations: Cochlear had drastically cut its FY26 profit guidance in April 2026 amid lower implant sales in developed markets, hospital capacity limits in Europe, slower-than-anticipated sales of its new Nucleus Nexa System, and a stronger Australian dollar. Despite the broader market's flat performance, Cochlear outperformed, indicating investors are reassessing the company's outlook in a positive light.",
  "summary": null,
  "key_points": [
    "Cochlear shares surged 7% to A$140.48",
    "Earnings beat expectations despite profit drop",
    "Optimism from revised FY26 profit guidance"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}